Exceptional responses to PARP inhibitors in patients with metastatic breast cancer in oncologic crisis.

MLA

Cheng, Joyce M., et al. “Exceptional Responses to PARP Inhibitors in Patients with Metastatic Breast Cancer in Oncologic Crisis.” Breast Cancer Research and Treatment, vol. 199, no. 2, June 2023, pp. 389–97. EBSCOhost, https://doi.org/10.1007/s10549-023-06910-6.

APA

Cheng, J. M., Canzoniero, J., Lee, S., Soni, S., Mangini, N., & Santa-Maria, C. A. (2023). Exceptional responses to PARP inhibitors in patients with metastatic breast cancer in oncologic crisis. Breast Cancer Research and Treatment, 199(2), 389–397. https://doi.org/10.1007/s10549-023-06910-6

Chicago

Cheng, Joyce M, Jenna Canzoniero, Seoho Lee, Sudeep Soni, Neha Mangini, and Cesar A Santa-Maria. 2023. “Exceptional Responses to PARP Inhibitors in Patients with Metastatic Breast Cancer in Oncologic Crisis.” Breast Cancer Research and Treatment 199 (2): 389–97. doi:10.1007/s10549-023-06910-6.